Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Non-neurogenic Voiding Dysfunction in Females
NCT00679315Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Jun 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alfuzosin in Voiding dysfunction, sponsored by Samsung Medical Center. Started Jun 2008; status: completed.
02
Drugs
alfuzosin
03
Conditions
Voiding dysfunction
Beyond the preview
Go deeper on NCT00679315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679315.